Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
MRK Merck & Co., Inc. weekly Stock Chart
MRK [NYSE]
Merck & Co., Inc.
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexDJIA S&P500 P/E24.59 EPS (ttm)3.31 Insider Own0.10% Shs Outstand2.70B Perf Week2.08%
Market Cap219.43B Forward P/E15.28 EPS next Y5.33 Insider Trans-32.71% Shs Float2.57B Perf Month-4.65%
Income8.76B PEG2.54 EPS next Q1.15 Inst Own78.10% Short Float0.75% Perf Quarter11.20%
Sales43.07B P/S5.09 EPS this Y33.00% Inst Trans0.26% Short Ratio1.84 Perf Half Y7.66%
Book/sh10.65 P/B7.64 EPS next Y12.15% ROA10.00% Target Price91.64 Perf Year29.31%
Cash/sh3.26 P/C24.94 EPS next 5Y9.68% ROE28.20% 52W Range62.01 - 87.07 Perf YTD6.52%
Dividend2.20 P/FCF72.13 EPS past 5Y10.60% ROI11.70% 52W High-6.52% Beta0.58
Dividend %2.70% Quick Ratio1.10 Sales past 5Y-0.80% Gross Margin69.10% 52W Low31.26% ATR1.56
Employees69000 Current Ratio1.40 Sales Q/Q7.80% Oper. Margin24.40% RSI (14)44.67 Volatility1.44% 1.83%
OptionableYes Debt/Eq0.94 EPS Q/Q321.80% Profit Margin19.50% Rel Volume1.09 Prev Close82.69
ShortableYes LT Debt/Eq0.83 EarningsJul 30 BMO Payout64.50% Avg Volume10.50M Price81.39
Recom1.70 SMA20-2.85% SMA50-0.63% SMA2004.47% Volume11,428,546 Change-1.57%
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Oct-31-17Upgrade Jefferies Underperform → Hold
Oct-30-17Downgrade SunTrust Buy → Hold
Oct-30-17Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-30-17Downgrade Barclays Overweight → Equal Weight $72 → $62
Oct-18-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade HSBC Securities Reduce → Hold
Jul-19-19 06:32PM  US Indexes Lower for the July 19 Week GuruFocus.com
05:54PM  Caterpillar (CAT) Set to Report Q2 Earnings: What to Expect Zacks
04:57PM  Is a Beat in the Cards for Bristol-Myers (BMY) Q2 Earnings? Zacks
10:32AM  Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study Zacks
09:53AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus Zacks
08:56AM  Dow 30 Stock Roundup: MSFT, JPM, IBM, JNJ, GS Earnings Impress Zacks
Jul-18-19 05:23PM  3 Key Takeaways From J&J's (JNJ) Q2 Earnings Announcement Zacks
11:11AM  Is a Beat in Store for Glaxo (GSK) This Earnings Season? Zacks
09:58AM  Novartis (NVS) Beats on Q2 Earnings & Sales, Raises Guidance Zacks
Jul-17-19 01:49PM  WHO declares Ebola outbreak is international health emergency Reuters
10:58AM  Seattle Genetics (SGEN) Q2 Loss Narrows, Sales Top Estimates Zacks
10:24AM  Merck's Antibiotic Recarbrio Gets FDA Nod for Infections Zacks
10:19AM  Mallinckrodt (MNK) Discontinues Sclerosis Study on Acthar Gel Zacks
10:07AM  Merck's Novel Antibiotic For Abdominal, Urinary Tract Infections Receives FDA Nod Benzinga
07:23AM  Merck stock up slightly after FDA approves Recarbrio for new indication MarketWatch
07:19AM  UPDATE 2-Merck's treatment for urinary, abdominal infections gets FDA approval Reuters
06:58AM  Merck's treatment for urinary, abdominal infections gets FDA approval Reuters
06:45AM  FDA Approves Mercks RECARBRIO (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available Business Wire
Jul-16-19 05:45PM  Merck (MRK) Gains As Market Dips: What You Should Know Zacks
04:19PM  Is a Beat in the Cards for Novartis' (NVS) Q2 Earnings? Zacks
10:51AM  Glaxo's Zejula Meets Goal in First-Line Ovarian Cancer Study Zacks
10:39AM  The Zacks Analyst Blog Highlights: Cisco, Home Depot, Merck, Humana and Public Service Enterprise Zacks
10:23AM  J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View Zacks
Jul-15-19 06:43PM  US Indexes Post Another Day of Closing Record Highs Monday GuruFocus.com
04:44PM  Top Stock Reports for Cisco, Home Depot & Merck Zacks
10:55AM  A Pairs Prescription for CVS Stock and Merck InvestorPlace
10:06AM  Livongo sets targets on IPO that could more than double its valuation American City Business Journals
09:05AM  J&J Falls Amid Reports of Criminal Probe Into Talcum Powder Zacks
06:00AM  Biden healthcare plan would curb drug prices, raise taxes on rich Reuters
Jul-14-19 11:10AM  Health companies start reporting earnings next week: Here are 3 things to keep in mind MarketWatch
Jul-13-19 07:00AM  Better Buy: AbbVie vs. Merck Motley Fool
Jul-12-19 02:33PM  Washington Worries Trigger Bearish Merck Options Trades Benzinga
11:35AM  Drug Pricing Woes Linger on Repealing Drug Rebate Proposal Zacks
11:28AM  AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC Zacks
10:40AM  Dow Breezes Past 27,000: 4 Blue-Chip Stocks to Buy Zacks
10:19AM  Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug Benzinga
09:39AM  Fridays Vital Data: Bed Bath & Beyond, CVS and Merck InvestorPlace
09:19AM  Dow 30 Stock Roundup: Cisco to Buy Acacia, Microsoft & ServiceNow Partnernership Zacks
08:36AM  Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY Zacks
Jul-11-19 06:42PM  Trump Drops Drug Rebate Proposal: What's Next and What Stocks to Play Zacks
04:39PM  Dow Jones Today: More Fed Fun, but Healthcare Weakness Caps Gains InvestorPlace
04:05PM  The Dow components that drove the blue-chip stock index to a 27,000 milestone MarketWatch
03:34PM  Bristol-Myers (BMY) Down 11.6% YTD: What Lies Ahead in 2H19? Zacks
03:00PM  4 Drug Stocks Getting Smashed InvestorPlace
01:35PM  Drug Stocks Are Falling Because Trumps Next Move on Pricing Could Be Trouble Barrons.com
01:30PM  Stocks - Dow Tops 27,000 as UnitedHealth Soars Investing.com
12:58PM  4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal Zacks
11:16AM  FDA Accepts Sanofi's BLA for Myeloma Candidate to Review Zacks
08:00AM  Pfizer Stock Is The Biggest Pharma But Should You Buy It? Investor's Business Daily
07:53AM  J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store? Zacks
06:07AM  Stocks - Health Insurers Drive Dow to New Record at Opening Investing.com
Jul-10-19 05:40PM  Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill Zacks
11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
10:14AM  Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA Zacks
09:15AM  Merck (MRK) is a Top Dividend Stock Right Now: Should You Buy? Zacks
06:45AM  Merck Highlights Commitment to HIV Research with Presentations for Investigational Anti-HIV Agent MK-8591 at IAS 2019 Business Wire
Jul-09-19 06:01PM  Novo Nordisk Reports Encouraging Data From Hemophilia Studies Zacks
05:55PM  Bayer-J&J Announce Positive Xarelto Data in Children with VTE Zacks
05:45PM  Merck (MRK) Outpaces Stock Market Gains: What You Should Know Zacks
05:32PM  Political Football Stocks GuruFocus.com
05:02PM  9 Health-Care Stocks for Your Portfolio Kiplinger
04:18PM  Dow Jones Today: Averting Catastrophe, but Nothing to Brag About InvestorPlace
06:45AM  FDA Accepts Mercks Supplemental Biologics License Applications for KEYTRUDA® (pembrolizumab) Six-Week Dosing Schedule for Melanoma and Multiple Other Indications Business Wire
Jul-08-19 06:36PM  UPDATE 4-U.S. judge strikes down Trump administration rule requiring drug prices in TV ads Reuters
06:25PM  U.S. judge halts rule requiring drug prices in TV ads Reuters
04:16PM  Bill Nygren's 2nd Quarter Market Commentary GuruFocus.com
03:21PM  Why Merck & Co., Inc.'s (NYSE:MRK) High P/E Ratio Isn't Necessarily A Bad Thing Simply Wall St.
02:36PM  Skyhawk Therapeutics adds Merck to nest of drug partners American City Business Journals
06:12AM  Merck Could Push Higher in the Weeks and Months Ahead - $100 Is in the Cards TheStreet.com
Jul-05-19 08:09PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
03:21PM  June jobs report crushes expectations as Fed weighs a rate cut Yahoo Finance Video
09:32AM  Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs Zacks
08:55AM  The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight Benzinga
06:00AM  Watch These 4 Japanese Drugmakers With Big Coming Events TheStreet.com
Jul-03-19 05:45PM  Merck (MRK) Outpaces Stock Market Gains: What You Should Know Zacks
01:29PM  Dow Jones Today: Almost Some Half-Day Fireworks InvestorPlace
09:34AM  Will the Pharma Space Witness More Mega-Merger Deals in 2H? Zacks
09:31AM  Stocks - Dow Shoots to Record Close Ahead of Holiday Investing.com
06:01AM  Merck Gets Boost From Analyst Buy Rating TheStreet.com
04:38AM  Stocks - Tesla Rises Premarket; Canopy Growth, Broadcom Slump Investing.com
Jul-02-19 06:48PM  Citing slower hiring, Merck to exit city, state incentive deals for Austin IT hub American City Business Journals
12:31PM  Weekly CFO Sales Highlight GuruFocus.com
12:03PM  Drugmakers raised prices of over 40 prescription drugs Yahoo Finance Video
Jul-01-19 10:21AM  The Zacks Analyst Blog Highlights: Chevron, Merck, Walgreens Boots, FedEx and Loews Zacks
10:10AM  Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report? Zacks
07:14AM  Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Benzinga
06:45AM  Merck to Hold Second-Quarter 2019 Sales and Earnings Conference Call on July 30 Business Wire
Jun-28-19 05:08PM  AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study Zacks
02:50PM  Top Research Reports for Chevron, Merck & Walgreens Boots Zacks
Jun-27-19 11:40AM  The Zacks Analyst Blog Highlights: Merck, Tractor Supply, IDEXX and CVS Zacks
10:54AM  Lilly's Study on Higher Doses of Trulicity Meets Endpoint Zacks
10:30AM  FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review Zacks
09:37AM  Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits Zacks
07:26AM  The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO Benzinga
Jun-26-19 05:51PM  Is Allergan a Good Deal for AbbVie? Zacks
04:45PM  CDC Advisory Committee on Immunization Practices (ACIP) Votes to Provisionally Recommend Shared Clinical Decision-Making for Vaccination of Adults Ages 27-45 with GARDASIL®9 & Harmonization of Catch-up Vaccination for Males and Females Through Age 26 Business Wire
01:37PM  Bernie Sanders' 'Medicare for all' matters when investing in health care stocks Yahoo Finance
08:51AM  4 Stocks to Make the Most of the Growing Love for Pets Zacks
08:00AM  Health-tech firm raises $26 million to bolster growth efforts, hire staff American City Business Journals
Jun-25-19 06:48PM  Merck, Coca-Cola and other top CEOs join NYSEs new council to advance corporate diversity Yahoo Finance
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases. It also provides neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, thyroid, and cervical cancer, as well as brain tumors; and prevent diseases caused by human papillomavirus, as well as offers vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it provides antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments; diabetes mellitus treatment and anthelmintic products; products to treat fleas and ticks in dogs and cats; fertility management products for horses; vaccines for dogs, cats, and horses; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Intec Pharma Ltd.; Nerviano Medical Sciences; and Healthy Interactions, Inc. The company serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, distributors, veterinarians, animal producers, and managed health care providers. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Robert MEVP, Global Svcs & CFOJun 25Option Exercise0.00216,7180354,378Jun 27 05:05 PM
Davis Robert MEVP, Global Svcs & CFOJun 25Sale85.43216,71818,514,032137,660Jun 27 05:05 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 10Option Exercise0.003,292022,412May 13 05:06 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 10Option Exercise0.004,389071,993May 13 05:05 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 10Option Exercise0.001,50903,317May 13 05:05 PM
Nally MichaelEVP, Chief Marketing OfficerMay 10Option Exercise0.001,81104,376May 13 05:06 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 07Option Exercise39.2925,000982,25092,604May 09 06:11 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 07Sale77.7325,0001,943,18367,604May 09 06:11 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.001,212019,717May 07 08:32 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise0.0069202,046May 07 08:32 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise0.005,77205,772May 07 07:42 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise0.001,29802,935May 07 07:40 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise0.001,904068,542May 07 07:37 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 03Option Exercise39.2935,0001,375,150106,064May 07 08:33 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 03Sale80.0035,0002,800,00071,064May 07 08:33 PM
Merck & Co., Inc.10% OwnerApr 08Buy16.004,121,68365,946,92812,955,016Apr 09 06:27 PM
Davis Robert MEVP, Global Svcs & CFOMar 25Option Exercise58.22192,57211,211,542330,232Mar 27 05:45 PM
Davis Robert MEVP, Global Svcs & CFOMar 25Sale82.38192,57215,863,119137,660Mar 27 05:45 PM
FRAZIER KENNETH CChairman, President & CEOMar 20Option Exercise39.29192,7367,572,597990,451Mar 20 06:49 PM
FRAZIER KENNETH CChairman, President & CEOMar 20Sale82.05192,73615,813,372797,715Mar 20 06:49 PM
FRAZIER KENNETH CChairman, President & CEOMar 13Option Exercise39.2918,725735,705816,440Mar 14 06:38 PM
FRAZIER KENNETH CChairman, President & CEOMar 13Sale82.0018,7251,535,454797,715Mar 14 06:38 PM
FRAZIER KENNETH CChairman, President & CEOMar 05Option Exercise39.296,961273,498804,676Mar 06 06:13 PM
FRAZIER KENNETH CChairman, President & CEOMar 05Sale82.006,961570,809797,715Mar 06 06:13 PM
FRAZIER KENNETH CChairman, President & CEOMar 04Option Exercise39.2913,144516,428810,859Mar 06 06:13 PM
FRAZIER KENNETH CChairman, President & CEOMar 04Sale82.0113,1441,077,875797,715Mar 06 06:13 PM
FRAZIER KENNETH CChairman, President & CEOFeb 22Option Exercise39.2953,9612,120,128745,911Feb 22 05:16 PM
FRAZIER KENNETH CChairman, President & CEOFeb 22Sale80.0253,9614,318,089691,950Feb 22 05:16 PM
FRAZIER KENNETH CChairman, President & CEOFeb 21Option Exercise39.2941,9921,649,866733,942Feb 22 05:16 PM
FRAZIER KENNETH CChairman, President & CEOFeb 21Sale80.0041,9923,359,452691,950Feb 22 05:16 PM
FRAZIER KENNETH CChairman, President & CEOFeb 19Option Exercise39.2942,7001,677,683734,650Feb 19 05:35 PM
FRAZIER KENNETH CChairman, President & CEOFeb 19Sale80.0242,7003,416,944691,950Feb 19 05:35 PM
FRAZIER KENNETH CChairman, President & CEOFeb 15Option Exercise39.2992,9133,650,552784,863Feb 19 05:35 PM
FRAZIER KENNETH CChairman, President & CEOFeb 15Sale80.0392,9137,436,162691,950Feb 19 05:35 PM
Karachun Rita ASr. VP Fince-Global ControllerFeb 14Option Exercise59.1664,6623,825,55180,837Feb 14 06:02 PM
Karachun Rita ASr. VP Fince-Global ControllerFeb 14Sale78.9664,6625,105,95116,175Feb 14 06:02 PM
WEEKS WENDELL PDirectorFeb 13Option Exercise24.305,000121,5005,100Feb 14 06:02 PM
WEEKS WENDELL PDirectorFeb 13Sale78.715,000393,548100Feb 14 06:02 PM
Chattopadhyay SanatExe V-P & Pres. MMDFeb 12Option Exercise38.1873,7272,815,241125,194Feb 14 06:02 PM
Chattopadhyay SanatExe V-P & Pres. MMDFeb 12Sale78.6273,7275,796,30651,467Feb 14 06:02 PM
BRUN LESLIE ADirectorFeb 08Option Exercise24.305,000121,5005,000Feb 11 05:33 PM
BRUN LESLIE ADirectorFeb 08Sale77.223,052235,6811,948Feb 11 05:33 PM
FRAZIER KENNETH CChairman, President & CEOFeb 05Option Exercise39.29231,5669,098,228923,516Feb 06 05:30 PM
FRAZIER KENNETH CChairman, President & CEOFeb 05Sale78.08231,56618,079,654691,950Feb 06 05:30 PM
PERLMUTTER ROGER MExe V-P & Pres, MRLNov 08Option Exercise44.98225,44310,140,426366,998Nov 08 04:31 PM
PERLMUTTER ROGER MExe V-P & Pres, MRLNov 08Sale75.27225,44316,967,967141,555Nov 08 04:31 PM
Gerberding Julie L.EVP Strat Comm, Gl Pub PolicyNov 07Option Exercise54.6836,2181,980,40082,481Nov 08 04:31 PM
Gerberding Julie L.EVP Strat Comm, Gl Pub PolicyNov 07Sale75.1436,2182,721,34846,263Nov 08 04:31 PM
Schechter Adam HEVP & Pres-Global Human HealthNov 01Option Exercise39.29277,87910,917,866277,879Nov 02 04:44 PM
Schechter Adam HEVP & Pres-Global Human HealthNov 01Sale73.81277,87920,510,9450Nov 02 04:44 PM
Watson AshleySVP Chief Ethics & Com OfficerOct 31Option Exercise58.3647,0362,745,21756,806Nov 01 05:07 PM
Watson AshleySVP Chief Ethics & Com OfficerOct 31Sale74.3347,0363,496,1589,770Nov 01 05:07 PM
DeLuca Richard R.EVP&Pres, Merck Animal HealthOct 30Option Exercise34.1925,467870,71782,135Nov 01 05:07 PM
DeLuca Richard R.EVP&Pres, Merck Animal HealthOct 30Sale72.0025,4671,833,73956,668Nov 01 05:07 PM
FRAZIER KENNETH CChairman, President & CEOOct 02Option Exercise36.56279,85010,231,316971,800Oct 03 05:26 PM
FRAZIER KENNETH CChairman, President & CEOOct 02Sale72.07279,85020,168,258691,950Oct 03 05:26 PM
Merck & Co., Inc.10% OwnerOct 01Buy15.00666,6669,999,9902,723,509Oct 02 02:31 PM
FRAZIER KENNETH CChairman, President & CEOSep 18Option Exercise36.56279,85110,231,353971,801Sep 19 05:43 PM
FRAZIER KENNETH CChairman, President & CEOSep 18Sale70.08279,85119,611,818691,950Sep 19 05:43 PM
Schechter Adam HEVP & Pres-Global Human HealthSep 17Option Exercise36.56100,0003,656,000100,000Sep 18 04:49 PM
Schechter Adam HEVP & Pres-Global Human HealthSep 17Sale70.187,360516,51155,406Sep 18 04:49 PM
Schechter Adam HEVP & Pres-Global Human HealthSep 17Sale70.18100,0007,017,7800Sep 18 04:49 PM
Chattopadhyay SanatExe V-P & Pres. MMDAug 03Option Exercise34.8629,2081,018,17680,675Aug 06 04:49 PM
Chattopadhyay SanatExe V-P & Pres. MMDAug 03Sale65.2029,2081,904,36251,467Aug 06 04:49 PM
Karachun Rita ASr. VP Fince-Global ControllerAug 02Sale65.015,000325,04016,175Aug 02 05:07 PM
FRAZIER KENNETH CChairman, President & CEOJul 31Option Exercise33.49228,0917,638,768938,788Aug 01 05:12 PM
FRAZIER KENNETH CChairman, President & CEOJul 31Sale65.00228,09114,826,691710,697Aug 01 05:12 PM
open in yahoo | open in reuters | open in google